We enable high-potential peptide- & protein-based products to become applicable for mass markets. Our innovative process allows the scalable and thus cost-efficient production of high-purity peptides & proteins for a broad range of applications. Gain access to new and previously inaccessible long peptides & proteins to develop new product IPs, improve existing products, and unlock new market potentials:. Substitutes for antibiotics or growth hormones for products that enable sustainable animal breeding.
Munich, Germany
Founded in 2017
1-10 Employees
Working industry
Biotechnology
Type of company
Manufacturer
Ownership structure
Public Company
Locations
1 Headquarter
Number of products
2 Products
Specialised areas
Biotechnology
mk2 Biotechnologies offers a wide range of products and services
Product
Solution - mk2 Biotechnologies
Go to product >
Product
Technology - mk2 Biotechnologies
Go to product >
An estimation about the ESG values based on digital data and signals. Important: The ESG scores are only based on information about the country, not the actual company itself
Country:
Germany
Overall risk estimation:
Very low
The ESG Data of countries are based on public sources
Environment
A
Grade (A-E)
View details
Social
A
Grade (A-E)
View details
Governance
A
Grade (A-E)
View details
mk2 Biotechnologies operates in 1 country around the world
Get an overview of the locations of mk2 Biotechnologies
Location
Country
State
City
Headquarter
Germany
Bavaria
Munich
Some frequent questions that have been asked about mk2 Biotechnologies
Where is mk2 Biotechnologies located?
The company headquarter of mk2 Biotechnologies is located in Munich, Bavaria, Germany. It's worth noting, that the company may have more locations
How many employees does mk2 Biotechnologies approximately have?
As of the latest available information mk2 Biotechnologies has around 1-10 employees worldwide.
When was mk2 Biotechnologies founded?
mk2 Biotechnologies was founded in 2017
In which industries does mk2 Biotechnologies mainly work?
The company mk2 Biotechnologies has it's main focus in the industries of Biotechnology
Check out some interesting alternative companies to mk2 Biotechnologies
Origin Peptides
Glasgow, United Kingdom
1-10 Employees
-
We are also at the cutting edge of applying our technology to the novel application of peptides to all scenarios - and are interested in your questions or problems we might be able to solve. One of the keys to Origin Peptides technology’s green credentials is the ability to perform peptide synthesis in an aqueous, one pot solution. Lower reaction volumes and greatly improved Product Manufacturing Index (PMI ~10)*. This novel and innovative process has been developed by Dr Sara ten Have. Enzymatic, materials, construction, food manufacture and environmental applications can now be considered as financially viable with this technology. To facilitate others to utilise this technology for their peptide production needs is our goal, to enable greener, cheaper and faster synthesis. Whether you are wanting to characterise your peptides, or their function, Proteomics is a useful tool to do this.
Infinite Enzymes
Jonesboro, United States
1-10 Employees
2006
Our industry-redefining proteins can meet growing demand within established markets while unlocking transformational growth through breakthrough applications. Our platform can scale production up or down with ease, helping meet a wide variety of demands along with delivering just-in-time manufacturing capabilities. By nature, our proprietary technology and processes drive exponentially sustainable protein production while also unlocking new protein-based greening opportunities. We start by optimizing and growing proteins using proprietary processes that enable industry-leading accumulation rates.Our plant-based technology has a ~96% success rate for commercially viable implantation. We produce proteins directly inside the corn kernel.By eliminating the need for a fermentation facility we save >$100MM in upfront costs, drive greener production, and reduce overhead.
peptides&elephants GmbH
Hennigsdorf, Germany
11-50 Employees
2001
We are a team that strives to be the new industry standard, creating change through innovation. We produce peptides that are used in a variety of applications and workflows, especially in the field of Immunology, such as drug discovery projects, establishing new therapies, development of novel vaccines, setting up new diagnostics and analytical methods or fundamental research. We are a dedicated team of highly qualified individuals ready to address your most challenging synthetic peptide requirements. USPS® enables us to produce hundreds of peptides overnight.
Zymtronix
Town of Ithaca, United States
11-50 Employees
2013
Our technology maximizes substrate conversions and overcomes product concentration limitations and purification costs. Combine productivity and precision by design to avoid unwanted byproducts and costs. Accelerate product development from discovery to production by working outside of the cell. Nutrition | Cosmetics | Agriculture | Animal-free products | Pharmaceuticals.
Space Peptides
Shanghai, China
- Employees
-
Space Peptides is a peptide CRO & CDMO specialized in Good Manufacture Practice (GMP) grade peptide manufacturing, from discovery, development to commercial use. It also provides in vitro / in vivo validation of the molecules of interests. Worldwide renowned for its research on chemical space. Hong focus on single-molecule scale electronics and instrumental engineering. Experienced sustainability and compliance expert with many years of experience in the Jacobs Foundation, PwC and the canton of Basel-Landschaft. Sustainability also offers a lot of business opportunities. Peptide synthesis process development and mid-scale manufacturing pilot plant (capacity 50kg/yr). Opening ceremony of large-scale peptide API manufacture plant (capacity 1100kg/yr).
PeptiSystems AB
Uppsala, Sweden
1-10 Employees
2014
PeptiSystems offers a new generation of synthesizers for production of peptide and oligonucleotide therapeutics. Research and Laboratory | Process Development | Large-scale production | Clinical trials. Unique linear scale-up technology uses the same synthesis parameters from process development in large-scale manufacturing. Real-time monitoring and graphical presentation of key parameters provides continuous detailed insight into synthesis progress and sends alarms/messages if needed. Large-scale synthesis | GMP Commercial Production | Clinical trials.